PAYLESS COMPOUNDERS, LLC recalls Semaglutide-Glycine-Cyanocobalamin Injectable, 2.5 mg, 5 mg, 1 MG/ML, 0.5 mL vials, Rx only, Northwest Compounders, Beav
Recalled April 22, 2026 · FDA recall D-0471-2026 · PAYLESS COMPOUNDERS
Hazard
Lack of Assurance of Sterility · FDA Class II
Units
91 vials
Sold at
OR
Description
Lack of Assurance of Sterility
Product
Semaglutide-Glycine-Cyanocobalamin Injectable, 2.5 mg, 5 mg, 1 MG/ML, 0.5 mL vials, Rx only, Northwest Compounders, Beaverton, OR
Manufacturer(s)
PAYLESS COMPOUNDERS, LLC
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →